SRN Advisors’s Thermo Fisher Scientific TMO Stock Holding History

SRN Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-455	Closed	-$226K	–	100
2025 Q1	$226K	Hold	455	–	–	0.25%	97
2024 Q4	$237K	Buy	+455	New	+$250K	0.21%	95
2022 Q4	–	Sell	-1,482	Closed	-$752K	–	120
2022 Q3	$752K	Sell	1,482 -282	-16%	-$158K	0.63%	63
2022 Q2	$958K	Sell	1,764 -294	-14%	-$162K	0.67%	62
2022 Q1	$1.22M	Buy	2,058 +33	+2%	+$19K	0.54%	72
2021 Q4	$1.35M	Buy	+2,025	New	+$1.26M	0.49%	67

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SRN Advisors's TMO Position: Q2 2025 in Review

SRN Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 455 shares — an estimated $226K sold.

SRN Advisors first reported a position in TMO in Q4 2021 and held it in 6 quarters. The position peaked at $1.35M in Q4 2021. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

SRN Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
SRN Advisors sold 455 Thermo Fisher Scientific shares in Q2 2025, an estimated $226K.
SRN Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 6 quarters.
SRN Advisors's Thermo Fisher Scientific position peaked at $1.35M in Q4 2021.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on SRN Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.